RRAGC
Basic information
Region (hg38): 1:38838198-38859772
Links
Phenotypes
GenCC
Source:
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Long-Olsen-Distelmaier syndrome | AD | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Cardiovascular; Neurologic; Ophthalmologic | 27234373; 37057673 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the RRAGC gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 20 | 21 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 1 | |||||
Total | 0 | 1 | 20 | 0 | 1 |
Variants in RRAGC
This is a list of pathogenic ClinVar variants found in the RRAGC region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
1-38839558-T-C | Inborn genetic diseases | Uncertain significance (Sep 25, 2023) | ||
1-38839580-G-T | Inborn genetic diseases | Uncertain significance (Aug 23, 2021) | ||
1-38839633-G-C | Inborn genetic diseases | Uncertain significance (Dec 04, 2024) | ||
1-38846038-T-C | Inborn genetic diseases | Uncertain significance (Sep 27, 2021) | ||
1-38846087-C-T | Inborn genetic diseases | Likely benign (Dec 27, 2023) | ||
1-38851747-A-C | Inborn genetic diseases | Uncertain significance (Jun 13, 2023) | ||
1-38851750-C-A | Inborn genetic diseases | Uncertain significance (May 26, 2022) | ||
1-38855750-T-A | RRAGC-related condition | Uncertain significance (Sep 21, 2024) | ||
1-38855750-T-C | Inborn genetic diseases | Uncertain significance (Jul 16, 2024) | ||
1-38855861-T-C | Inborn genetic diseases | Uncertain significance (May 02, 2024) | ||
1-38855886-T-C | Inborn genetic diseases | Uncertain significance (May 01, 2023) | ||
1-38856967-G-A | Long-Olsen-Distelmaier syndrome | Pathogenic (Mar 07, 2025) | ||
1-38856977-A-G | See cases • Long-Olsen-Distelmaier syndrome | Likely pathogenic (Aug 15, 2022) | ||
1-38856978-T-C | Inborn genetic diseases | Uncertain significance (Feb 28, 2023) | ||
1-38856997-G-A | Inborn genetic diseases | Uncertain significance (Jun 13, 2022) | ||
1-38857003-T-C | Inborn genetic diseases | Uncertain significance (Feb 07, 2025) | ||
1-38857051-G-T | Long-Olsen-Distelmaier syndrome | Pathogenic (Mar 07, 2025) | ||
1-38859391-T-C | Benign (Jan 25, 2021) | |||
1-38859423-G-T | Long-Olsen-Distelmaier syndrome | Pathogenic (Mar 07, 2025) | ||
1-38859480-C-T | Inborn genetic diseases | Uncertain significance (Sep 26, 2024) | ||
1-38859483-C-G | Inborn genetic diseases | Uncertain significance (Dec 20, 2022) | ||
1-38859484-C-G | Inborn genetic diseases | Uncertain significance (Dec 09, 2024) | ||
1-38859487-G-A | Inborn genetic diseases | Uncertain significance (Aug 30, 2022) | ||
1-38859516-A-G | Inborn genetic diseases | Uncertain significance (Apr 25, 2023) | ||
1-38859519-C-A | Inborn genetic diseases | Uncertain significance (Apr 09, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
RRAGC | protein_coding | protein_coding | ENST00000373001 | 7 | 21626 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.975 | 0.0246 | 125742 | 0 | 6 | 125748 | 0.0000239 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.46 | 113 | 215 | 0.527 | 0.00000996 | 2660 |
Missense in Polyphen | 15 | 44.978 | 0.3335 | 595 | ||
Synonymous | 0.623 | 76 | 83.2 | 0.913 | 0.00000440 | 736 |
Loss of Function | 3.45 | 1 | 15.8 | 0.0633 | 7.48e-7 | 206 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000579 | 0.0000579 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000163 | 0.000163 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00 | 0.00 |
Middle Eastern | 0.000163 | 0.000163 |
South Asian | 0.0000364 | 0.0000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Guanine nucleotide-binding protein forming heterodimeric Rag complexes required for the amino acid-induced relocalization of mTORC1 to the lysosomes and its subsequent activation by the GTPase RHEB. This is a crucial step in the activation of the TOR signaling cascade by amino acids. {ECO:0000269|PubMed:20381137, ECO:0000269|PubMed:27234373}.;
- Disease
- DISEASE: Note=RRAGC mutations have been found in a patient with idiopathic dilated cardiomyopathy with ventricular dilation and systolic dysfunction, bilateral cataracts, and mild facial dysmorphisms. {ECO:0000269|PubMed:27234373}.;
- Pathway
- mTOR signaling pathway - Homo sapiens (human);Autophagy - animal - Homo sapiens (human);Target Of Rapamycin (TOR) Signaling;Signal Transduction;Gene expression (Transcription);Generic Transcription Pathway;RNA Polymerase II Transcription;mTORC1-mediated signalling;Energy dependent regulation of mTOR by LKB1-AMPK;mTOR signalling;TP53 Regulates Metabolic Genes;Macroautophagy;Cellular responses to external stimuli;Regulation of PTEN gene transcription;PTEN Regulation;PIP3 activates AKT signaling;Transcriptional Regulation by TP53;Intracellular signaling by second messengers;mTOR signaling pathway
(Consensus)
Recessive Scores
- pRec
- 0.117
Intolerance Scores
- loftool
- 0.175
- rvis_EVS
- -0.23
- rvis_percentile_EVS
- 36.86
Haploinsufficiency Scores
- pHI
- 0.372
- hipred
- Y
- hipred_score
- 0.765
- ghis
- 0.608
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.990
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Rragc
- Phenotype
Gene ontology
- Biological process
- transcription, DNA-templated;apoptotic process;cell cycle arrest;small GTPase mediated signal transduction;RNA splicing;cellular response to starvation;regulation of autophagy;regulation of macroautophagy;regulation of TOR signaling;positive regulation of TOR signaling;cellular response to amino acid starvation;cellular protein localization;response to amino acid;cellular response to amino acid stimulus;regulation of TORC1 signaling
- Cellular component
- nucleus;cytoplasm;lysosome;cytosol;EGO complex;intracellular membrane-bounded organelle;Gtr1-Gtr2 GTPase complex
- Molecular function
- magnesium ion binding;GTPase activity;protein binding;GTP binding;GDP binding;protein heterodimerization activity;GTPase binding